| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 6.30e-07 | 15 | 95 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 8.47e-07 | 37 | 95 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 9.72e-07 | 38 | 95 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | calcium ion binding | TTYH1 COMP PCDHB10 PCDHB9 CDH23 GRM7 CRP CAPN8 THBS3 FAT1 THBS4 DCHS1 CDH2 CDH4 CDH12 | 2.41e-06 | 749 | 95 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 8.58e-06 | 9 | 95 | 3 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 8.58e-06 | 9 | 95 | 3 | GO:0001640 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.58e-05 | 112 | 95 | 6 | GO:0090079 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.33e-05 | 120 | 95 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 1.34e-04 | 4 | 95 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.79e-04 | 188 | 95 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.81e-04 | 27 | 95 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | actin binding | 4.62e-04 | 479 | 95 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.61e-04 | 599 | 95 | 10 | GO:0050839 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 7.89e-04 | 9 | 95 | 2 | GO:0043878 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL12A1 COMP MYOM1 COL6A6 MAP2 LAMA4 KLHL3 THBS3 THBS4 ERVK-18 NUP133 ACTL6B | 1.05e-03 | 891 | 95 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | cadherin binding | 1.18e-03 | 339 | 95 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | U1 snRNP binding | 1.43e-03 | 12 | 95 | 2 | GO:1990446 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 2.26e-03 | 15 | 95 | 2 | GO:0004029 | |
| GeneOntologyMolecularFunction | snRNP binding | 2.57e-03 | 16 | 95 | 2 | GO:0070990 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 4.56e-09 | 53 | 95 | 7 | GO:0016339 | |
| GeneOntologyBiologicalProcess | female meiosis II | 6.29e-09 | 6 | 95 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 6.29e-09 | 6 | 95 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 6.29e-09 | 6 | 95 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.05e-07 | 187 | 95 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 3.96e-06 | 91 | 95 | 6 | GO:0032272 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 5.84e-06 | 26 | 95 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 7.79e-06 | 9 | 95 | 3 | GO:0007196 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 9.18e-06 | 29 | 95 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.21e-05 | 31 | 95 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.42e-05 | 313 | 95 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 2.48e-05 | 37 | 95 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 2.49e-05 | 75 | 95 | 5 | GO:0030837 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MKKS FLII FLNA FLNC COL12A1 COMP MYOM1 MAP2 MYO5B KANK2 FAM171A1 FAT1 KANK1 CSNK1D SSH3 | 3.04e-05 | 957 | 95 | 15 | GO:0097435 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | TTYH1 FLNA COMP PSG6 PCDHB10 PCDHB9 CDH23 PPARA ITGAD FAT1 THBS4 DCHS1 ACTL6B CDH2 CDH4 CDH12 | 3.07e-05 | 1077 | 95 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 5.08e-05 | 16 | 95 | 3 | GO:0007216 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 5.44e-05 | 45 | 95 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 6.47e-05 | 47 | 95 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 9.65e-05 | 52 | 95 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | 1.28e-04 | 618 | 95 | 11 | GO:0090066 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | 1.50e-04 | 173 | 95 | 6 | GO:0031333 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | 1.54e-04 | 426 | 95 | 9 | GO:0032535 | |
| GeneOntologyBiologicalProcess | protein polymerization | 1.56e-04 | 334 | 95 | 8 | GO:0051258 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.58e-04 | 59 | 95 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 2.31e-04 | 354 | 95 | 8 | GO:0071695 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 2.78e-04 | 194 | 95 | 6 | GO:0051494 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 3.02e-04 | 197 | 95 | 6 | GO:1902904 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MKKS FLII FLNA FLNC MYOM1 MYO5B KANK2 FAM171A1 FAT1 KANK1 SSH3 HRG | 3.15e-04 | 803 | 95 | 12 | GO:0030036 |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 3.17e-04 | 29 | 95 | 3 | GO:0003417 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | FLNA MAP2 MYO5B ADGRB3 SPART CDH23 CFAP43 SEMA4C FAM171A1 FAT1 THBS4 KANK1 CDH2 CDH4 CDH12 | 3.53e-04 | 1194 | 95 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | translational initiation | 3.64e-04 | 132 | 95 | 5 | GO:0006413 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 4.00e-04 | 75 | 95 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 4.42e-04 | 77 | 95 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 5.61e-04 | 82 | 95 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | actin filament organization | 5.67e-04 | 509 | 95 | 9 | GO:0007015 | |
| GeneOntologyBiologicalProcess | podocyte cell migration | 5.77e-04 | 8 | 95 | 2 | GO:0090521 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 6.72e-04 | 151 | 95 | 5 | GO:0045727 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 6.72e-04 | 86 | 95 | 4 | GO:0007193 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 7.01e-04 | 231 | 95 | 6 | GO:0032271 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 7.02e-04 | 87 | 95 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 7.33e-04 | 88 | 95 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 7.67e-04 | 39 | 95 | 3 | GO:0003416 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 7.78e-04 | 156 | 95 | 5 | GO:0030833 | |
| GeneOntologyBiologicalProcess | behavior | MKKS OXR1 PSG6 ADGRB3 CDH23 PPARA GRM2 GRM4 GRM7 THBS4 SORCS3 CSMD1 | 7.93e-04 | 891 | 95 | 12 | GO:0007610 |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 8.31e-04 | 91 | 95 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 8.37e-04 | 239 | 95 | 6 | GO:0031032 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 8.66e-04 | 92 | 95 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | negative regulation of lamellipodium organization | 9.22e-04 | 10 | 95 | 2 | GO:1902744 | |
| GeneOntologyBiologicalProcess | developmental maturation | 9.55e-04 | 439 | 95 | 8 | GO:0021700 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MKKS FLII FLNA FLNC MYOM1 MYO5B KANK2 FAM171A1 FAT1 KANK1 SSH3 HRG | 9.70e-04 | 912 | 95 | 12 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.01e-03 | 443 | 95 | 8 | GO:1903311 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 1.12e-03 | 11 | 95 | 2 | GO:0035095 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.14e-03 | 99 | 95 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | bone growth | 1.17e-03 | 45 | 95 | 3 | GO:0098868 | |
| GeneOntologyCellularComponent | catenin complex | 3.36e-07 | 32 | 96 | 5 | GO:0016342 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 3.24e-06 | 7 | 96 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 1.51e-05 | 11 | 96 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 7.63e-05 | 223 | 96 | 7 | GO:0098862 | |
| GeneOntologyCellularComponent | filopodium | 2.59e-04 | 123 | 96 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | actin-based cell projection | 2.97e-04 | 278 | 96 | 7 | GO:0098858 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.48e-04 | 477 | 96 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | dendritic shaft | 3.76e-04 | 74 | 96 | 4 | GO:0043198 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 4.26e-04 | 137 | 96 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | stereocilium bundle | 4.82e-04 | 79 | 96 | 4 | GO:0032421 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 6.76e-04 | 523 | 96 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.43e-04 | 530 | 96 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | endosome lumen | 1.01e-03 | 43 | 96 | 3 | GO:0031904 | |
| GeneOntologyCellularComponent | glutamatergic synapse | FLNA MAP2 MYO5B ADGRB3 GRM2 CSMD2 GRM4 GRM7 SEMA4C SORCS3 CDH2 | 1.30e-03 | 817 | 96 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 1.83e-03 | 14 | 96 | 2 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 1.83e-03 | 14 | 96 | 2 | GO:0060091 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.36e-03 | 201 | 96 | 5 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.64e-03 | 405 | 96 | 7 | GO:0045211 | |
| Domain | Aspartic_peptidase_N | 1.99e-08 | 7 | 93 | 4 | IPR012848 | |
| Domain | A1_Propeptide | 1.99e-08 | 7 | 93 | 4 | PF07966 | |
| Domain | Cadherin_CS | 7.01e-08 | 109 | 93 | 8 | IPR020894 | |
| Domain | RRM_1 | 8.55e-08 | 208 | 93 | 10 | PF00076 | |
| Domain | CADHERIN_1 | 9.29e-08 | 113 | 93 | 8 | PS00232 | |
| Domain | Cadherin | 9.29e-08 | 113 | 93 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 9.95e-08 | 114 | 93 | 8 | PS50268 | |
| Domain | - | 9.95e-08 | 114 | 93 | 8 | 2.60.40.60 | |
| Domain | CA | 1.06e-07 | 115 | 93 | 8 | SM00112 | |
| Domain | Cadherin-like | 1.14e-07 | 116 | 93 | 8 | IPR015919 | |
| Domain | Aspartic_peptidase_A1 | 1.18e-07 | 10 | 93 | 4 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 1.18e-07 | 10 | 93 | 4 | IPR033121 | |
| Domain | Asp | 1.18e-07 | 10 | 93 | 4 | PF00026 | |
| Domain | PEPTIDASE_A1 | 1.18e-07 | 10 | 93 | 4 | PS51767 | |
| Domain | Thbs/COMP_coiled-coil | 1.20e-07 | 3 | 93 | 3 | IPR024665 | |
| Domain | COMP | 1.20e-07 | 3 | 93 | 3 | PF11598 | |
| Domain | RRM | 1.27e-07 | 217 | 93 | 10 | SM00360 | |
| Domain | Cadherin | 1.30e-07 | 118 | 93 | 8 | IPR002126 | |
| Domain | RRM_dom | 1.93e-07 | 227 | 93 | 10 | IPR000504 | |
| Domain | RRM | 2.18e-07 | 230 | 93 | 10 | PS50102 | |
| Domain | - | 2.77e-07 | 12 | 93 | 4 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 2.77e-07 | 12 | 93 | 4 | PS00141 | |
| Domain | - | 3.77e-07 | 244 | 93 | 10 | 3.30.70.330 | |
| Domain | Aspartic_peptidase_AS | 3.98e-07 | 13 | 93 | 4 | IPR001969 | |
| Domain | - | 4.67e-07 | 95 | 93 | 7 | 2.60.120.200 | |
| Domain | Nucleotide-bd_a/b_plait | 6.28e-07 | 258 | 93 | 10 | IPR012677 | |
| Domain | TSP_3 | 1.19e-06 | 5 | 93 | 3 | PF02412 | |
| Domain | TSP3 | 1.19e-06 | 5 | 93 | 3 | PS51234 | |
| Domain | TSP_CTER | 1.19e-06 | 5 | 93 | 3 | PS51236 | |
| Domain | - | 1.19e-06 | 5 | 93 | 3 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.19e-06 | 5 | 93 | 3 | IPR008859 | |
| Domain | TSP_C | 1.19e-06 | 5 | 93 | 3 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 1.19e-06 | 5 | 93 | 3 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 1.19e-06 | 5 | 93 | 3 | IPR003367 | |
| Domain | TSP_type-3_rpt | 1.19e-06 | 5 | 93 | 3 | IPR028974 | |
| Domain | Peptidase_aspartic_dom | 1.30e-06 | 17 | 93 | 4 | IPR021109 | |
| Domain | GPCR_3_mtglu_rcpt | 6.57e-06 | 8 | 93 | 3 | IPR000162 | |
| Domain | Laminin_G | 1.02e-05 | 58 | 93 | 5 | IPR001791 | |
| Domain | RBM39_linker | 2.45e-05 | 2 | 93 | 2 | IPR029123 | |
| Domain | RBM39linker | 2.45e-05 | 2 | 93 | 2 | PF15519 | |
| Domain | RBM39_SF | 2.45e-05 | 2 | 93 | 2 | IPR006509 | |
| Domain | NCD3G | 3.30e-05 | 13 | 93 | 3 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 3.30e-05 | 13 | 93 | 3 | IPR011500 | |
| Domain | GPCR_3_CS | 4.18e-05 | 14 | 93 | 3 | IPR017979 | |
| Domain | ConA-like_dom | 1.12e-04 | 219 | 93 | 7 | IPR013320 | |
| Domain | KN_motif | 1.46e-04 | 4 | 93 | 2 | IPR021939 | |
| Domain | KN_motif | 1.46e-04 | 4 | 93 | 2 | PF12075 | |
| Domain | GPCR_3 | 1.49e-04 | 21 | 93 | 3 | IPR000337 | |
| Domain | 7tm_3 | 1.72e-04 | 22 | 93 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.72e-04 | 22 | 93 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.72e-04 | 22 | 93 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.72e-04 | 22 | 93 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.72e-04 | 22 | 93 | 3 | PS50259 | |
| Domain | GPCR_3_C | 1.72e-04 | 22 | 93 | 3 | IPR017978 | |
| Domain | TSPN | 1.97e-04 | 23 | 93 | 3 | SM00210 | |
| Domain | Cadherin_cytoplasmic-dom | 2.54e-04 | 25 | 93 | 3 | IPR000233 | |
| Domain | Cadherin_C | 2.54e-04 | 25 | 93 | 3 | PF01049 | |
| Domain | Catenin_binding_dom | 3.98e-04 | 29 | 93 | 3 | IPR027397 | |
| Domain | - | 3.98e-04 | 29 | 93 | 3 | 4.10.900.10 | |
| Domain | Cadherin_pro | 5.07e-04 | 7 | 93 | 2 | PF08758 | |
| Domain | Cadherin_pro_dom | 6.74e-04 | 8 | 93 | 2 | IPR014868 | |
| Domain | RBM1CTR | 6.74e-04 | 8 | 93 | 2 | PF08081 | |
| Domain | RBM1CTR | 6.74e-04 | 8 | 93 | 2 | IPR012604 | |
| Domain | Cadherin_pro | 6.74e-04 | 8 | 93 | 2 | SM01055 | |
| Domain | ANF_lig-bd_rcpt | 8.21e-04 | 37 | 93 | 3 | IPR001828 | |
| Domain | ANF_receptor | 8.21e-04 | 37 | 93 | 3 | PF01094 | |
| Domain | EGF_CA | 8.96e-04 | 86 | 93 | 4 | PF07645 | |
| Domain | Peripla_BP_I | 9.59e-04 | 39 | 93 | 3 | IPR028082 | |
| Domain | IG_FLMN | 1.08e-03 | 10 | 93 | 2 | SM00557 | |
| Domain | Filamin | 1.31e-03 | 11 | 93 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.31e-03 | 11 | 93 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.31e-03 | 11 | 93 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.31e-03 | 11 | 93 | 2 | IPR017868 | |
| Domain | EGF_Ca-bd_CS | 1.40e-03 | 97 | 93 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.51e-03 | 99 | 93 | 4 | PS01187 | |
| Domain | CUB | 2.34e-03 | 53 | 93 | 3 | PS01180 | |
| Domain | VWA | 2.74e-03 | 56 | 93 | 3 | PF00092 | |
| Domain | Ald_DH_CS_GLU | 2.81e-03 | 16 | 93 | 2 | IPR029510 | |
| Domain | CUB_dom | 2.88e-03 | 57 | 93 | 3 | IPR000859 | |
| Domain | Ald_DH_CS_CYS | 3.18e-03 | 17 | 93 | 2 | IPR016160 | |
| Domain | EGF_CA | 3.23e-03 | 122 | 93 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.43e-03 | 124 | 93 | 4 | IPR001881 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 3.56e-03 | 18 | 93 | 2 | PS00687 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 3.56e-03 | 18 | 93 | 2 | PS00070 | |
| Domain | Ald_DH_C | 3.97e-03 | 19 | 93 | 2 | IPR016163 | |
| Domain | Ald_DH_N | 3.97e-03 | 19 | 93 | 2 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 3.97e-03 | 19 | 93 | 2 | IPR016161 | |
| Domain | - | 3.97e-03 | 19 | 93 | 2 | 3.40.605.10 | |
| Domain | Aldedh | 3.97e-03 | 19 | 93 | 2 | PF00171 | |
| Domain | Aldehyde_DH_dom | 3.97e-03 | 19 | 93 | 2 | IPR015590 | |
| Domain | - | 3.97e-03 | 19 | 93 | 2 | 3.40.309.10 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 2.25e-07 | 11 | 74 | 4 | M39726 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.01e-06 | 84 | 74 | 6 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.85e-06 | 258 | 74 | 9 | MM14572 | |
| Pathway | WP_OVARIAN_INFERTILITY | 3.24e-05 | 35 | 74 | 4 | MM15948 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.95e-05 | 73 | 74 | 5 | MM15126 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 6.04e-05 | 15 | 74 | 3 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 6.04e-05 | 15 | 74 | 3 | MM15845 | |
| Pathway | KEGG_FOCAL_ADHESION | 8.13e-05 | 199 | 74 | 7 | M7253 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.47e-04 | 96 | 74 | 5 | MM14592 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.71e-04 | 300 | 74 | 8 | M610 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 3.69e-04 | 117 | 74 | 5 | M19248 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 5.09e-04 | 30 | 74 | 3 | M27566 | |
| Pathway | WP_FOCAL_ADHESION | 6.13e-04 | 199 | 74 | 6 | M39402 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 9.49e-04 | 37 | 74 | 3 | MM15067 | |
| Pubmed | 3.79e-11 | 10 | 97 | 5 | 10601091 | ||
| Pubmed | 5.68e-11 | 4 | 97 | 4 | 7670487 | ||
| Pubmed | 5.68e-11 | 4 | 97 | 4 | 11694340 | ||
| Pubmed | 5.68e-11 | 4 | 97 | 4 | 9321470 | ||
| Pubmed | 5.68e-11 | 4 | 97 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 5.68e-11 | 4 | 97 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 5.68e-11 | 4 | 97 | 4 | 11688365 | |
| Pubmed | 5.68e-11 | 4 | 97 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 5.68e-11 | 4 | 97 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 5.68e-11 | 4 | 97 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 5.68e-11 | 4 | 97 | 4 | 15066457 | |
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 5.68e-11 | 4 | 97 | 4 | 23047493 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 5.68e-11 | 4 | 97 | 4 | 11095434 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 5.68e-11 | 4 | 97 | 4 | 11915945 | |
| Pubmed | 5.68e-11 | 4 | 97 | 4 | 8322031 | ||
| Pubmed | 5.68e-11 | 4 | 97 | 4 | 12698190 | ||
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 5.68e-11 | 4 | 97 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 5.68e-11 | 4 | 97 | 4 | 16963411 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 1.92e-10 | 13 | 97 | 5 | 23816659 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 23579190 | ||
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 2.84e-10 | 5 | 97 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 2.84e-10 | 5 | 97 | 4 | 17416365 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 22293198 | ||
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 2.84e-10 | 5 | 97 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 2.84e-10 | 5 | 97 | 4 | 8968756 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 2.84e-10 | 5 | 97 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 2.84e-10 | 5 | 97 | 4 | 26411291 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 2.84e-10 | 5 | 97 | 4 | 14648873 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 8896558 | ||
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 2.84e-10 | 5 | 97 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 2.84e-10 | 5 | 97 | 4 | 9288969 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 2.84e-10 | 5 | 97 | 4 | 10903443 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 2.84e-10 | 5 | 97 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 2.84e-10 | 5 | 97 | 4 | 8845845 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 2.84e-10 | 5 | 97 | 4 | 19783541 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 17761180 | ||
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 2.84e-10 | 5 | 97 | 4 | 12200456 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 11514340 | ||
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 2.84e-10 | 5 | 97 | 4 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 2.84e-10 | 5 | 97 | 4 | 23223451 | |
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 22066020 | ||
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 11804965 | ||
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 21270429 | ||
| Pubmed | 2.84e-10 | 5 | 97 | 4 | 8661148 | ||
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 2.98e-10 | 14 | 97 | 5 | 14611631 | |
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 8.49e-10 | 6 | 97 | 4 | 18452650 | |
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 8.49e-10 | 6 | 97 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 8.49e-10 | 6 | 97 | 4 | 31355046 | |
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 20157580 | ||
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 8.49e-10 | 6 | 97 | 4 | 26077710 | |
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 17526644 | ||
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 8.49e-10 | 6 | 97 | 4 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 8.49e-10 | 6 | 97 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 8.49e-10 | 6 | 97 | 4 | 23417416 | |
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 32170089 | ||
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 16278232 | ||
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 8.49e-10 | 6 | 97 | 4 | 16001084 | |
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 8.49e-10 | 6 | 97 | 4 | 1869307 | |
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 11390979 | ||
| Pubmed | 8.49e-10 | 6 | 97 | 4 | 27632217 | ||
| Pubmed | 1.98e-09 | 7 | 97 | 4 | 15081113 | ||
| Pubmed | 1.98e-09 | 7 | 97 | 4 | 22699423 | ||
| Pubmed | 1.98e-09 | 7 | 97 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 1.98e-09 | 7 | 97 | 4 | 16946704 | |
| Pubmed | 1.98e-09 | 7 | 97 | 4 | 10857750 | ||
| Pubmed | 1.98e-09 | 7 | 97 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 1.98e-09 | 7 | 97 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 1.98e-09 | 7 | 97 | 4 | 26826184 | |
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 3.95e-09 | 8 | 97 | 4 | 23204224 | |
| Pubmed | 3.95e-09 | 8 | 97 | 4 | 29883445 | ||
| Pubmed | 3.95e-09 | 8 | 97 | 4 | 10823932 | ||
| Pubmed | 3.95e-09 | 8 | 97 | 4 | 11869379 | ||
| Pubmed | 3.95e-09 | 8 | 97 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 3.95e-09 | 8 | 97 | 4 | 32339196 | |
| Pubmed | 3.95e-09 | 8 | 97 | 4 | 33749946 | ||
| Pubmed | 3.95e-09 | 8 | 97 | 4 | 22621333 | ||
| Pubmed | 3.95e-09 | 8 | 97 | 4 | 32686646 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 7.09e-09 | 9 | 97 | 4 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 7.09e-09 | 9 | 97 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 7.09e-09 | 9 | 97 | 4 | 19695304 | |
| Pubmed | 7.09e-09 | 9 | 97 | 4 | 28235998 | ||
| Pubmed | 7.09e-09 | 9 | 97 | 4 | 20159962 | ||
| Pubmed | 1.18e-08 | 10 | 97 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 1.18e-08 | 10 | 97 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 1.18e-08 | 10 | 97 | 4 | 38433229 | |
| Cytoband | Yq11.223 | 5.00e-08 | 93 | 97 | 6 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 5.43e-05 | 311 | 97 | 6 | chrYq11 | |
| Cytoband | 3p21.2 | 7.38e-04 | 19 | 97 | 2 | 3p21.2 | |
| GeneFamily | RNA binding motif containing | 7.74e-09 | 213 | 69 | 10 | 725 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 2.94e-06 | 8 | 69 | 3 | 281 | |
| GeneFamily | Cadherin related | 3.48e-05 | 17 | 69 | 3 | 24 | |
| GeneFamily | Ankyrin repeat domain containing|KN motif and ankyrin repeat domain containing | 8.57e-05 | 4 | 69 | 2 | 623 | |
| GeneFamily | CD molecules|Type I classical cadherins | 1.42e-04 | 5 | 69 | 2 | 1185 | |
| GeneFamily | Aldehyde dehydrogenases | 2.35e-03 | 19 | 69 | 2 | 398 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 7.84e-08 | 12 | 95 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 7.84e-08 | 12 | 95 | 4 | MM781 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.23e-07 | 33 | 95 | 5 | MM701 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 1.36e-06 | 23 | 95 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 4.73e-06 | 31 | 95 | 4 | MM765 | |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP | 1.04e-05 | 136 | 95 | 6 | M1894 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | 2.63e-05 | 429 | 95 | 9 | M45694 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | TMC7 MAP2 ADGRB3 CSMD2 GRM4 GRM7 CPEB4 SDC3 SORCS3 CSMD1 CDH4 | 4.83e-05 | 703 | 95 | 11 | M39070 |
| Coexpression | SENESE_HDAC1_TARGETS_DN | 5.42e-05 | 267 | 95 | 7 | M6100 | |
| CoexpressionAtlas | stomach | 6.19e-06 | 160 | 92 | 7 | stomach | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-09 | 164 | 94 | 8 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.07e-07 | 179 | 94 | 7 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 200 | 94 | 7 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 2.28e-07 | 200 | 94 | 7 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-06 | 173 | 94 | 6 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-06 | 173 | 94 | 6 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.89e-06 | 174 | 94 | 6 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.15e-06 | 178 | 94 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 178 | 94 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 185 | 94 | 6 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 185 | 94 | 6 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 2.69e-06 | 185 | 94 | 6 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-06 | 186 | 94 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 187 | 94 | 6 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 187 | 94 | 6 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-06 | 188 | 94 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-06 | 188 | 94 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.95e-06 | 188 | 94 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 189 | 94 | 6 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 189 | 94 | 6 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 189 | 94 | 6 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 190 | 94 | 6 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-06 | 190 | 94 | 6 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-06 | 194 | 94 | 6 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.75e-06 | 196 | 94 | 6 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-06 | 196 | 94 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.86e-06 | 197 | 94 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.97e-06 | 198 | 94 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.97e-06 | 198 | 94 | 6 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.97e-06 | 198 | 94 | 6 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-06 | 200 | 94 | 6 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 4.21e-06 | 200 | 94 | 6 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.21e-06 | 200 | 94 | 6 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 151 | 94 | 5 | 0de76acd1b204345dce7f33be2a1ed9fbe9e6da0 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 151 | 94 | 5 | 20b9c8fb966c5d62ff909cc4a4616b109b78cdca | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 151 | 94 | 5 | bee48137d1f5f27a24571a59c835284651d38538 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.95e-05 | 155 | 94 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.20e-05 | 159 | 94 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.71e-05 | 166 | 94 | 5 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-05 | 171 | 94 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 3.21e-05 | 172 | 94 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.58e-05 | 176 | 94 | 5 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.68e-05 | 177 | 94 | 5 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.68e-05 | 177 | 94 | 5 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.89e-05 | 179 | 94 | 5 | 4f20540bfbcefe0e83812be7ea542e8bb3bf19bc | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 180 | 94 | 5 | 35c73670da90cb6924e822a2426d13a675685f09 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.10e-05 | 181 | 94 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 182 | 94 | 5 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 183 | 94 | 5 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 183 | 94 | 5 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 183 | 94 | 5 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 183 | 94 | 5 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 184 | 94 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 184 | 94 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 184 | 94 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.43e-05 | 184 | 94 | 5 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 185 | 94 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 185 | 94 | 5 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 185 | 94 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 186 | 94 | 5 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 186 | 94 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 186 | 94 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 186 | 94 | 5 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 186 | 94 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 187 | 94 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 187 | 94 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 187 | 94 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 4.78e-05 | 187 | 94 | 5 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | 15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class | 4.78e-05 | 187 | 94 | 5 | be9fce9e74b2f170a2067f1b31d802912a578329 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 187 | 94 | 5 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-05 | 188 | 94 | 5 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 188 | 94 | 5 | a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.91e-05 | 188 | 94 | 5 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.91e-05 | 188 | 94 | 5 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 188 | 94 | 5 | 54550313db78b3b5b572fa1e67092c8f6f33aab5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.91e-05 | 188 | 94 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.91e-05 | 188 | 94 | 5 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 188 | 94 | 5 | 794fc1d9a726945c42f7eac221eed938309b47a9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.03e-05 | 189 | 94 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 189 | 94 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 5.03e-05 | 189 | 94 | 5 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 190 | 94 | 5 | e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.16e-05 | 190 | 94 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 190 | 94 | 5 | f32d66c0e74e0a2a23ecb857c4daf0d8573a806c | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 5.16e-05 | 190 | 94 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | droplet-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 190 | 94 | 5 | b79ffd05806244a9790cd04c66fb4f92c824e69f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 190 | 94 | 5 | 050d6e0546954675b6adbfecb67854b1e09739d1 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 190 | 94 | 5 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 190 | 94 | 5 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 190 | 94 | 5 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 191 | 94 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| Computational | Adhesion molecules. | 1.17e-04 | 141 | 59 | 6 | MODULE_122 | |
| Drug | boron trichloride | 4.06e-09 | 6 | 94 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 4.54e-09 | 16 | 94 | 5 | CID000162558 | |
| Drug | 3-bromo-7-nitroindazole | 7.43e-09 | 36 | 94 | 6 | CID000001649 | |
| Drug | AZFd | 3.42e-08 | 23 | 94 | 5 | CID000196489 | |
| Drug | bipy | 1.55e-07 | 97 | 94 | 7 | CID000001474 | |
| Drug | Vistar | 3.67e-07 | 36 | 94 | 5 | CID000040896 | |
| Drug | Rgd Peptide | 6.52e-07 | 239 | 94 | 9 | CID000104802 | |
| Drug | 2-chlorodideoxyadenosine | 9.16e-07 | 43 | 94 | 5 | CID000072194 | |
| Drug | aminocyclopentane | 1.01e-06 | 19 | 94 | 4 | CID000002906 | |
| Drug | dazmegrel | 1.01e-06 | 19 | 94 | 4 | CID000053555 | |
| Drug | YM 026 | 1.01e-06 | 19 | 94 | 4 | CID000004443 | |
| Drug | dansylaziridine | 2.27e-06 | 23 | 94 | 4 | CID000104008 | |
| Drug | ridogrel | 2.40e-06 | 52 | 94 | 5 | CID005362391 | |
| Drug | cis-MCG-I | 3.76e-06 | 8 | 94 | 3 | CID003035584 | |
| Drug | azafagomine | 3.81e-06 | 57 | 94 | 5 | CID011957435 | |
| Drug | mM PEP | 5.62e-06 | 9 | 94 | 3 | CID005311462 | |
| Drug | AC1N21PP | 5.62e-06 | 9 | 94 | 3 | CID004014619 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 5.62e-06 | 9 | 94 | 3 | CID000107216 | |
| Drug | d-gluconhydroximo-1,5-lactam | 7.87e-06 | 31 | 94 | 4 | CID000003479 | |
| Drug | NS-105 | 8.01e-06 | 10 | 94 | 3 | CID000198695 | |
| Drug | cyclobutylene AP5 | 1.10e-05 | 11 | 94 | 3 | CID000126582 | |
| Drug | p11-13 | 1.48e-05 | 75 | 94 | 5 | CID000015759 | |
| Drug | benzyloxyaspartate | 1.62e-05 | 37 | 94 | 4 | CID004133412 | |
| Drug | aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 2664_UP | |
| Drug | Iodixanol [92339-11-2]; Up 200; 2.6uM; HL60; HT_HG-U133A | 1.83e-05 | 198 | 94 | 7 | 3023_UP | |
| Drug | Mspg | 1.89e-05 | 13 | 94 | 3 | CID003964410 | |
| Drug | MSOPPE | 1.89e-05 | 13 | 94 | 3 | CID005311463 | |
| Drug | AC1NSKBB | 1.89e-05 | 13 | 94 | 3 | CID005311256 | |
| Drug | DETC-MeSO | 2.01e-05 | 39 | 94 | 4 | CID003035711 | |
| Drug | MTPG | 2.40e-05 | 14 | 94 | 3 | CID005311456 | |
| Drug | 2-methyl-6-styrylpyridine | 2.40e-05 | 14 | 94 | 3 | CID000235382 | |
| Drug | D-N-Q | 2.57e-05 | 84 | 94 | 5 | CID000003140 | |
| Drug | molybdenum disulfide | 2.97e-05 | 43 | 94 | 4 | CID000014823 | |
| Drug | propham | 3.26e-05 | 44 | 94 | 4 | CID000024685 | |
| Drug | ethylglutamate | 3.67e-05 | 16 | 94 | 3 | CID000014241 | |
| Drug | 2-PMPA | 3.67e-05 | 16 | 94 | 3 | CID010130754 | |
| Drug | BW755C | 4.20e-05 | 93 | 94 | 5 | CID000047795 | |
| Drug | oriens | 4.33e-05 | 154 | 94 | 6 | CID000161645 | |
| Drug | 3HPG | 4.44e-05 | 17 | 94 | 3 | CID000001217 | |
| Drug | lonazolac | 4.44e-05 | 17 | 94 | 3 | CID000068706 | |
| Drug | acromelic acid A | 5.32e-05 | 18 | 94 | 3 | CID000108086 | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 7.38e-05 | 20 | 94 | 3 | CID000001297 | |
| Drug | 3,4-dihydroxyphenylglycine | 8.59e-05 | 21 | 94 | 3 | CID000027915 | |
| Drug | T 50 | 8.59e-05 | 21 | 94 | 3 | CID000468848 | |
| Drug | GYKI 52466 | 9.75e-05 | 58 | 94 | 4 | CID000003538 | |
| Drug | AC1L1GUK | 1.01e-04 | 4 | 94 | 2 | CID000003847 | |
| Drug | perfluorohexanoic acid | 1.01e-04 | 4 | 94 | 2 | CID000067542 | |
| Drug | Kalpaamruthaa | 1.01e-04 | 4 | 94 | 2 | ctd:C510231 | |
| Drug | Copper bleomycin | 1.01e-04 | 4 | 94 | 2 | CID000124115 | |
| Drug | Cbpg | 1.01e-04 | 4 | 94 | 2 | CID005311040 | |
| Drug | AC1O3F30 | 1.01e-04 | 4 | 94 | 2 | CID006327012 | |
| Drug | hyaluronan | 1.10e-04 | 263 | 94 | 7 | CID000024759 | |
| Drug | MSOP | 1.14e-04 | 23 | 94 | 3 | CID003964633 | |
| Drug | heptafluorobutyric acid | 1.14e-04 | 23 | 94 | 3 | CID000009777 | |
| Drug | carbonyl sulfide | 1.20e-04 | 116 | 94 | 5 | CID000010039 | |
| Drug | NSC56408 | 1.27e-04 | 62 | 94 | 4 | CID000005604 | |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 1.30e-04 | 24 | 94 | 3 | CID003645780 | |
| Drug | kt S | 1.61e-04 | 66 | 94 | 4 | CID006399216 | |
| Drug | AC1NQH9B | 1.65e-04 | 26 | 94 | 3 | CID005221504 | |
| Drug | 8-HETE | 1.65e-04 | 26 | 94 | 3 | CID000001898 | |
| Drug | AC1L350B | 1.67e-04 | 5 | 94 | 2 | CID000083237 | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; HL60; HG-U133A | 1.78e-04 | 199 | 94 | 6 | 1586_DN | |
| Drug | L-Glutamic Acid | 1.81e-04 | 68 | 94 | 4 | DB00142 | |
| Drug | Capobenic acid | 1.86e-04 | 27 | 94 | 3 | CID000030627 | |
| Drug | norbiotin | 2.26e-04 | 72 | 94 | 4 | CID000446903 | |
| Drug | 1-cyclopenta-2,4-dienylmethanol;cyclopentane;iron | 2.50e-04 | 6 | 94 | 2 | CID011986411 | |
| Drug | mono(2-ethyl-5-oxohexyl)phthalate | 2.50e-04 | 6 | 94 | 2 | ctd:C080276 | |
| Drug | oxindanac | 2.50e-04 | 6 | 94 | 2 | CID000068879 | |
| Drug | AC1Q5R6K | 2.50e-04 | 6 | 94 | 2 | CID000114973 | |
| Drug | lora | 2.50e-04 | 6 | 94 | 2 | CID000019094 | |
| Drug | AC1MBZ3L | 2.50e-04 | 6 | 94 | 2 | CID002733524 | |
| Drug | azelastine | 2.51e-04 | 74 | 94 | 4 | CID000002267 | |
| Drug | PBDA | 2.55e-04 | 30 | 94 | 3 | CID000004408 | |
| Disease | Male sterility due to Y-chromosome deletions | 5.12e-09 | 8 | 88 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 5.12e-09 | 8 | 88 | 4 | C1507149 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.40e-05 | 16 | 88 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.40e-05 | 16 | 88 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.40e-05 | 16 | 88 | 3 | 415000 | |
| Disease | Pasteurellaceae Infections | 2.63e-05 | 3 | 88 | 2 | C0085397 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 2.63e-05 | 3 | 88 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Schizophrenia | MYO5B CYP3A5 CP PPARA GRM2 CSMD2 GRM4 GRM7 CRP HSPA12A CSMD1 | 6.35e-05 | 883 | 88 | 11 | C0036341 |
| Disease | mitral valve prolapse (is_implicated_in) | 3.12e-04 | 9 | 88 | 2 | DOID:988 (is_implicated_in) | |
| Disease | pneumonia, COVID-19 | 3.71e-04 | 113 | 88 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | glucagon-like peptide-1 measurement | 3.90e-04 | 10 | 88 | 2 | EFO_0008465 | |
| Disease | obesity (implicated_via_orthology) | 4.70e-04 | 215 | 88 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | IGHV3-49 POC1A CYP3A5 GRM7 PAOX HSPA12A SORCS3 CSMD1 ALDH3B2 OPLAH | 5.11e-04 | 945 | 88 | 10 | EFO_0005653 |
| Disease | Psoriasis | 6.68e-04 | 57 | 88 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 6.68e-04 | 57 | 88 | 3 | C0030246 | |
| Disease | attention deficit hyperactivity disorder | 6.78e-04 | 354 | 88 | 6 | EFO_0003888 | |
| Disease | Global developmental delay | 6.86e-04 | 133 | 88 | 4 | C0557874 | |
| Disease | macrophage inflammatory protein 1b measurement | 7.46e-04 | 136 | 88 | 4 | EFO_0008219 | |
| Disease | Hypertriglyceridemia | 9.00e-04 | 15 | 88 | 2 | C0020557 | |
| Disease | Alcoholic Intoxication, Chronic | 1.26e-03 | 268 | 88 | 5 | C0001973 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.45e-03 | 19 | 88 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Amphetamine-Related Disorders | 1.48e-03 | 75 | 88 | 3 | C0236733 | |
| Disease | behavioural disinhibition measurement | 1.48e-03 | 75 | 88 | 3 | EFO_0006946 | |
| Disease | Amphetamine Abuse | 1.48e-03 | 75 | 88 | 3 | C0236807 | |
| Disease | Amphetamine Addiction | 1.48e-03 | 75 | 88 | 3 | C0236804 | |
| Disease | freckles | 1.61e-03 | 20 | 88 | 2 | EFO_0003963 | |
| Disease | sex interaction measurement, bilirubin measurement | 1.95e-03 | 22 | 88 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | Nerve Degeneration | 1.98e-03 | 83 | 88 | 3 | C0027746 | |
| Disease | urinary albumin to creatinine ratio | 2.05e-03 | 179 | 88 | 4 | EFO_0007778 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 2.14e-03 | 23 | 88 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 2.14e-03 | 23 | 88 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 2.14e-03 | 23 | 88 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 2.14e-03 | 23 | 88 | 2 | C0014556 | |
| Disease | nighttime rest measurement | 2.33e-03 | 24 | 88 | 2 | EFO_0007827 | |
| Disease | TEMPS-A questionnaire | 2.52e-03 | 25 | 88 | 2 | EFO_0004783 | |
| Disease | response to venlafaxine | 2.52e-03 | 25 | 88 | 2 | EFO_0006328 | |
| Disease | psychosis predisposition measurement | 2.73e-03 | 26 | 88 | 2 | EFO_0008337 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GIGFYGNSETSDGVS | 106 | Q9H313 | |
| VGTEDGSVYFISVYD | 446 | Q8NDM7 | |
| SSGGGEFLEATYFIS | 141 | P61568 | |
| DGYVSSGLERGGFTF | 3436 | Q96PZ7 | |
| DGYDFLEVTGTEGSS | 251 | Q7Z408 | |
| ATSVGFTRTKGYGTD | 996 | O60242 | |
| FGAYSMDVITGTSFG | 176 | P20815 | |
| FDIGSFSVRAGYAGE | 16 | O94805 | |
| AVGYTAFNGVDFEGT | 571 | P49747 | |
| YVSTVASEGDYGETG | 206 | Q14416 | |
| SEGSYGESGVEAFIQ | 226 | Q14833 | |
| TADFQGGGTTEGYFL | 1086 | Q8IYW2 | |
| SVVSGTLRSAFEYGG | 331 | P30038 | |
| VEGFEDFTGGISEFY | 201 | A6NHC0 | |
| SSGSFGGNEGFTYIS | 301 | P48448 | |
| TGVSKGYGFVSFVND | 76 | Q13117 | |
| TGVSKGYGFVSFVND | 76 | Q9NR90 | |
| SYFITGGNVDGKFSV | 1031 | Q9H251 | |
| ATGVEYFNTFGGSPV | 301 | Q8IUZ5 | |
| YGSSSYVASIVDGGE | 471 | A6NDE4 | |
| YGSSSYVASIVDGGE | 471 | Q15415 | |
| DEGSYVGGFAVVEYS | 266 | Q9HCJ3 | |
| GRSKGYGFITFSDSE | 301 | Q86U06 | |
| ETGRSKGYGFITFSD | 286 | Q14498 | |
| VVIFGGIDSSYYTGS | 226 | P0DJD9 | |
| AVFFEQGTTRIGGSY | 406 | P00450 | |
| FITSSGEEYSGGVIG | 3551 | Q14517 | |
| AGEDTYTEAFVDSGG | 191 | Q8WUM0 | |
| SSFDFTVTAVDGGGL | 651 | Q96JQ0 | |
| TVAFSRTGEYFASGG | 276 | Q8NBT0 | |
| GTSGTDGVAFIKFQY | 66 | Q5VUB5 | |
| DTSDTGEGTVVVSYG | 251 | Q9NPJ1 | |
| IEGGTASGFYTVEDT | 601 | Q13045 | |
| VRGGEGTGYFVDFSV | 186 | P04196 | |
| KGFLYFETSAQTGEG | 156 | Q9NZQ0 | |
| FASGQYGGITEFVAD | 146 | Q5HYC2 | |
| GFSRGSVEEFYVAGL | 1466 | Q8IVV2 | |
| GSGSFGDIYLGTDIA | 16 | P48730 | |
| TYFDIYTAGAGTGDV | 396 | Q14315 | |
| FVGINGGYETTSSDD | 996 | Q14678 | |
| YSGSDTVGAGFTQAK | 266 | O43301 | |
| AGSGFGRYSVTEETE | 26 | Q9UN67 | |
| GGTTEYAASVKGRFT | 76 | A0A0A0MS15 | |
| VVIFGGIDSSYYTGS | 226 | P0DJD8 | |
| YSSTEGSGGRITFNV | 411 | P48551 | |
| VAIGGSENFYSVFEG | 26 | P56537 | |
| AEVTGTQIGSYFGAS | 446 | Q13349 | |
| SDGFYGTGETFVFTF | 786 | Q8N573 | |
| VFTDGSSNGKVAYTG | 466 | Q9QC07 | |
| TGVSKGYGFVSFVND | 76 | Q9NQZ3 | |
| TGVSKGYGFVSFVND | 241 | Q9NQZ3 | |
| TGVSKGYGFVSFVND | 406 | Q9NQZ3 | |
| SGFSVFVVGVADVDY | 2451 | Q99715 | |
| AFGGVDVAEFSSRYG | 526 | Q8N8A6 | |
| TTYFEIFTAGAGTGE | 401 | P21333 | |
| GYITGTSVEVTGGLF | 246 | Q92506 | |
| TYDTEFFFGASGSPV | 531 | Q96PZ2 | |
| LVFDYEGSGSTAGSV | 866 | P55283 | |
| SKDIGYSFTVGGSEI | 86 | P02741 | |
| FVGVNGGYESSSEDS | 501 | Q63ZY3 | |
| SEGSYGEKGVESFTQ | 226 | Q14831 | |
| GFDGSTGLASVEAYS | 401 | Q9UH77 | |
| RFSGSGYGTDFTLTI | 81 | P06315 | |
| YTLSGDGAGTVFTID | 91 | P55289 | |
| TGFDYQEATGLGTST | 141 | Q17RY0 | |
| TGVSKGYGFVSFVND | 76 | Q86SG3 | |
| TGVSKGYGFVSFVND | 241 | Q86SG3 | |
| GSGSGYFEQESGIET | 81 | O75056 | |
| LVFDYEGSGSTAGSL | 856 | P19022 | |
| GSSDKYFFVETFGGL | 961 | A6NMZ7 | |
| VVIFGGIDSSYYTGS | 226 | P0DJD7 | |
| ETGTYFSTEGGYVVL | 1646 | Q16363 | |
| IGEDSSGSFGFTEYQ | 41 | Q07869 | |
| AGSGFGRYSVTEETE | 26 | Q9Y5E1 | |
| SYSYVAVGSTGGDLD | 436 | Q6QHF9 | |
| AGGSSGGVETTVDFY | 311 | O00358 | |
| YTDIGVFISSDGGNT | 586 | Q9UPU3 | |
| GGVTGYFTVTLYSET | 131 | Q00889 | |
| GGTSTDVSRYAGEFE | 316 | O14841 | |
| FYGTGIGVHFTSAVT | 251 | Q96RA2 | |
| VGSAYVPESVGSFTG | 216 | Q9C0C4 | |
| TQVYLDGDGGFSVTS | 171 | Q8TE77 | |
| VGYTAFNGVDFEGTF | 771 | P35443 | |
| SYGTDSGEFSSVGEE | 186 | Q8N0X7 | |
| GSVYEGGVFFLDITF | 96 | Q96LR5 | |
| SGSLTGFFGYDTLTV | 136 | P20142 | |
| SGGAVVFGGVDSSLY | 221 | P20142 | |
| GTSVFLSVTGEQYGS | 166 | Q9HCN8 | |
| FAGVSESYNGTGELG | 481 | Q6ZQN7 | |
| DTFRGVAFVGGFSYA | 1106 | O15067 | |
| AVGYTAFNGVDFEGT | 766 | P49746 | |
| GFESGDFVSFSEVQG | 241 | P22314 | |
| GTYHVVGFDGSSTVD | 1006 | Q9ULM0 | |
| SENLSGESGTFYEGT | 886 | P11137 | |
| SYGTAFEVTSGGSLQ | 61 | Q9UJA5 | |
| VSAFANTEGGYVFFG | 216 | Q08AF3 | |
| GEGSGVARSFYTAIA | 2286 | O95071 | |
| SIEGKFGTGIQSYFS | 151 | Q7Z402 | |
| FGVLTFSDGSRYEGE | 51 | Q8NDC4 | |
| GGFDGSTGLSSVEAY | 406 | O95198 | |
| FYTSQGGDTSIEGVD | 286 | Q9ULV0 | |
| FTINGVSTADSGKYG | 1631 | P52179 |